What Emergent BioSolutions Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 2 | 15 |
| Total trades | 2 | 59 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 1,113,964 |
| Disposed | 20,800 | 367,995 |
| Net activity | −20,800 | +745,969 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| DeGolyer Donald W | Director | Oct 07 | Sale for tax withholding · S | −17,800 | $7.09 | −$126K | 111,921 |
| Williams Paul Anthony | SVP, Products Business | Oct 01 | Disclosed 10b5-1 sale · S | −3,000 | $6.53 | −$19.6K | 156,098 |
| Williams Paul Anthony | SVP, Products Business | Jul 01 | Disclosed 10b5-1 sale · S | −3,000 | $8.40 | −$25.2K | 159,098 |
| Hartzel William | SVP, Bioservices | Jun 08 | Withheld — tax / exercise cost · F | −1,741 | $8.00 | −$13.9K | 185,558 |
| Glessner Coleen | EVP, Quality & Ethics, and CPL | Jun 08 | Withheld — tax / exercise cost · F | −2,018 | $8.00 | −$16.1K | 202,201 |
| Lindahl Richard S | EVP, Chief Financial Officer | Jun 08 | Withheld — tax / exercise cost · F | −3,964 | $8.00 | −$31.7K | 374,083 |
| Williams Paul Anthony | SVP, Products Business | Jun 08 | Withheld — tax / exercise cost · F | −694 | $8.00 | −$5.55K | 162,098 |
| Zoon Kathryn C | Director | May 01 | Sale for tax withholding · S | −1,057 | $8.97 | −$9.48K | 79,941 |
| Zoon Kathryn C | Director | May 01 | Sale for tax withholding · S | −16,145 | $8.36 | −$135K | 80,998 |
| DeGolyer Donald W | Director | May 01 | Sale for tax withholding · S | −954 | $8.96 | −$8.55K | 129,721 |
| DeGolyer Donald W | Director | May 01 | Sale for tax withholding · S | −14,527 | $8.36 | −$121K | 130,675 |
| Dayal Sujata Tyagi | Director | May 01 | Sale for tax withholding · S | −980 | $8.94 | −$8.76K | 100,563 |
| Dayal Sujata Tyagi | Director | May 01 | Sale for tax withholding · S | −12,781 | $8.36 | −$107K | 101,543 |
| Fowler Neal Franklin | Director | Apr 30 | Grant / award · A | +25,344 | — | — | 160,847 |
| Zoon Kathryn C | Director | Apr 30 | Grant / award · A | +25,344 | — | — | 97,143 |
| Harsanyi Zsolt | Chairman | Apr 30 | Grant / award · A | +25,344 | — | — | 149,076 |
| White Marvin L | Director | Apr 30 | Grant / award · A | +25,344 | — | — | 113,839 |
| Richard Ronald | Director | Apr 30 | Grant / award · A | +25,344 | — | — | 123,761 |
| Katkin Keith | Director | Apr 30 | Sale for tax withholding · S | −15,481 | $8.28 | −$128K | 96,294 |
| Katkin Keith | Director | Apr 30 | Grant / award · A | +25,344 | — | — | 111,775 |
Loading...
